Life Science Network

Powered by CG Life, the Life Science Network (LSN) is a relaxed community of life science professionals, researchers, communicators, marketers and advocates.

[Life Science Network @lifescience]

A fabulous, complimentary life science networking reception is coming up during Advances in Single Cell & Spatial Biology on 9/14. CG Life is co-hosting. It should make for an excellent evening of drinks, bites, and science! https://t.co/KHwu30H7i1

[Life Science Network @lifescience]

Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal https://t.co/HD0NIPmFDH

[Life Science Network @lifescience]

New Cancer Therapy Target Stops Tumor Cells From Sharing Resources https://t.co/QDLGtWMnAc

[Life Science Network @lifescience]

Oncolytic Virus Improves Survival in Glioblastoma Trial https://t.co/7wCStG3Eks via @GENbio

[Life Science Network @lifescience]

Seed-stage Bay Area biotechs kick off return of BIO Investor Forum - San Francisco Business Times https://t.co/YqivQ7q38x via @SFBusinessTimes

[Life Science Network @lifescience]

Carl Icahn sues Illumina board members over Grail acquisition - https://t.co/jkdyrxFnCz

[Life Science Network @lifescience]

Flipped coins found not to be as fair as thought https://t.co/2KiKCZRqqo via @physorg_com

[Life Science Network @lifescience]

Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessary - https://t.co/0nDcLbwsPA

[Life Science Network @lifescience]

These Japanese life science firms came to San Diego to study startups https://t.co/DNztLfdgpn

[Life Science Network @lifescience]

Better Therapeutics begins rolling out digital app for Type 2 diabetes https://t.co/vXvDE3l8XN

[Life Science Network @lifescience]

Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug https://t.co/H8Wvld4gQW

[Life Science Network @lifescience]

Thermo Fisher Scientific to buy Olink in $3.1 billion deal https://t.co/vo3tjJzBw0

[Life Science Network @lifescience]

Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup - https://t.co/SuM7M78yA7

[Gwendolyn Wu @gwendolynawu]

A decade later, biotech’s CRISPR revolution is still going strong. I traced the history of gene editing startups and what it means for the future. The result? A deep dive into the schools and scientists who mold the future of medicine. For @BioPharmaDive https://t.co/d5W1B9A6TT

[Life Science Network @lifescience]

Chemogenetics Can Dampen Pain Responses in Lab Tests https://t.co/u4GFke4GyB via @clinicalomics

[Life Science Network @lifescience]

Cell Therapy for Drug-Resistant Epilepsy a Preclinical Success https://t.co/xNDK3ADUjC via @GENbio

[Life Science Network @lifescience]

Twist Bioscience, Bayer Enter Antibody Discovery Deal Valued at up to $188 Million https://t.co/3SWU36NejT via @clinicalomics

[CG Life @cglifeagency]

Researchers are using CRISPR for more complex diseases such as Alzheimer's. Studies done at @UCSanDiego, @DukeU, and more are using CRISPR to target genes found in properties responsible for the disease.

Read more from @DrewQJoseph at @statnews: https://t.co/1jckBxAeb2

[Life Science Network @lifescience]

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone $ETON https://t.co/icokJXBwQr via $ETON

[Life Science Network @lifescience]

BridgeBio and Resilience Form Gene Therapy Partnership https://t.co/IJLb4vizFv via @GENbio

[Life Science Network @lifescience]

Gilead stops another CD47 study, this time in acute myeloid leukemia - https://t.co/5nwN4zFT3R